Faculty

Institution

Unit

Venue

Mark Brantly

University of Florida

Affiliations

College of Medicine

Pulmonary, Critical Care, and Sleep Medicine

NoneMark Brantly is currently serving as a College Of Medicine faculty at University of Florida.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Mark Brantly

University of Florida

You can click a keyword to filter the displayed items

pharmacology respiratory medicine immunology genetics medicine hematology hepatology inflammation medicinal research gene expression veterinary medicine human genetics membrane biology liver physiology liver disease digestive diseases tumor biology vascular biology clinical immunology protein science mammalian biology chronic obstructive pulmonary disease clinical evidence cytokines molecular physiology enzyme inhibition pulmonary diseases innate immune system hermansky-pudlak syndrome experimental medicine neutrophil elastase virus research clinical investigation cellular physiology clinical biochemistry protein secretion allelic variant viral genetics cell regulation clinical gastroenterology biochemical efficacy lung function clinical transplantation clinical medicine phagocytes antibody engineering transplantation medicine cohort studies cell adhesion pulmonary fibrosis treatment response airflow obstruction clinical features recombinant adeno-associated virus lung disease treatment effects genomic medicine advanced lung disease genome-wide association studies computed tomography protein genetics pulmonary circulation pediatric gastroenterology functional modification rna biology gene characterization enzyme specificity viral oncology in vivo systems pharmacokinetics adeno-associated virus vectors second mutation lung inflammation mouse model pulmonary hypertension cytokine production

Video Presentations

Notable Scholarly Works

Notable Federal Grants

Collaborators

Berberine Potentiates Liver Inflammation and Fibrosis in the Pi*Z Haat Transgenic Murine Model. PLoS ONE (2024)

Yuanqing LuNaweed S MohammadJungnam LeeAlek M AranyosKarina A SerbanMark L Brantly

pharmacologyhepatologyliver inflammation

Extracellular Vesicle-Associated Neutrophil Elastase Activates Hepatic Stellate Cells and Promotes Liver Fibrogenesis via Erk1/2 Pathway. bioRxiv (Cold Spring Harbor Laboratory) (2024)

Regina OshinsZachary GreenbergYun-Ling TaiDerrick ZhaoXuan WangBorna MehradMei HeIshan PatelLaith KhartabilHuiping ZhouMark BrantlyNazli Khodayari

enzymesmolecular biologyhepatic stellate cellsbiochemistrycell biology

Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (Sequoia). Gastroenterology (2024)

Virginia C. ClarkCharlie StrangePavel StrnadAntonio J. SanchezPaul KwoVitor Magno PereiraBart van HoekIgor BarjaktarevicAngelo Guido CorsicoMonica PonsMonica GoldklangMeagan GrayBrooks KuhnHugo E. VargasJohn M. VierlingRaj VuppalanchiMark BrantlyNaomi KappeTing ChangThomas SchluepRong ZhouJames HamiltonJavier San MartinRohit Loomba

digestive diseasesmedicineclinical gastroenterologypharmacologyanticoagulantsrandomized controlled trialshematologyliver diseasefamily medicineclinical trialsgastroenterologyhepatology

Inhaled Alpha-1-Antitrypsin (Aat) Restores Lower Respiratory Tract Protease- Anti-Protease Homeostasis and Reduces Inflammation in Aat-Deficient Individuals: A Randomised Phase 2 Study. ERJ Open Research (2024)

Mark BrantlyJames StocksJorge LascanoTammy FlaggAnn M. JeffersShuzi Z. OwensTorry A. TuckerMegan DevineNoga AlagemNaveh Tov

pharmacologyreduces inflammationrespiratory medicineanti-inflammatoryaat-deficient individualsinflammation

Liver Characterization of a Cohort of Alpha-1 Antitrypsin Deficiency Patients With and Without Lung Disease. Journal of Clinical and Translational Hepatology (2024)

Naweed MohammadRegina OshinsTongjun GuVirginia ClarkJorge LascanoNaziheh AssarzadeganGeorge MarekMark BrantlyNazli Khodayari

immunologypulmonary diseasespharmacologyclinical immunologyliver characterizationglobal healthhepatologyclinical epidemiologyrespiratory medicinecohort studiestranslational medicinelung disease

Monocyte Nlrp3 Inflammasome and Interleukin-1β Activation Modulated by Alpha-1 Antitrypsin Therapy in Deficient Individuals. Thorax (2024)

Debananda GogoiHoward YuMichelle CaseyRory BairdAzeez YusufLuke FordeMichael E O' BrienJesse R WestTammy FlaggNoel G McElvaneyEdward EdenChristian MuellerMark L BrantlyPatrick GeraghtyEmer P Reeves

immunologymedicinepharmacologyclinical immunologycell signalingcytokinesinnate immune systemimmune responsesdeficient individualsinflammation

Novel Transgenic Humanized Alpha-1 Antitrypsin Deficiency Mouse Model on Murine Serpina1 Null Background. bioRxiv (Cold Spring Harbor Laboratory) (2024)

Regina OshinsAlek M. AranyosSkylar GreyNaweed MohammadYuanqing LuJorge E. LascanoTammy FlaggKarina SerbanMark BrantlyNazli Khodayari

immunologygene therapygeneticsknockout micemolecular biology

Plasma Extracellular Vesicle-Derived Microrna Associated With Human Alpha-1 Antitrypsin Deficiency-Mediated Liver Disease. Journal of Clinical and Translational Hepatology (2024)

Regina OshinsZhiguang HuoZachary GreenbergVirginia ClarkSergio DuarteHuiping ZhouJesse WestMei HeMark BrantlyNazli Khodayari

translational researchliver diseasehepatologyhealth sciencestranslational medicine

Profiling Plasma Extracellular Vesicle-Derived Micrornas for Noninvasive Diagnosis of Liver Disease Associated With Alpha-1 Antitrypsin Deficiency. (2024)

Regina OshinsZhiguang HuoBrittney PooleVirginia ClarkHuiping ZhouJesse WestMark BrantlyZachary GreenbergMei HeNazli Khodayari

immunologydigestive diseasesdermatologypharmacologyhematologyclinical microbiologyliver diseasenoninvasive diagnosismolecular diagnosticsoncologyhepatologyinnovative diagnostics

Recombinant Alpha-1 Antitrypsin–Fc Fusion Protein Inbrx-101 in Adults With Alpha-1 Antitrypsin Deficiency: A Phase 1 Study. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation (2024)

Mark L. BrantlyBrooks T. KuhnHumam W. FarahRavi MahadevaAlexandra ColeCatherina L. ChangCynthia D. BrownMichael A. CamposJorge E. LascanoErin K. BabcockSharvari P. BhagwatTeresa F. BoyeaCarson A. VeldstraVasily AndrianovJames L. KalabusBrendan P. EckelmanAndrew G. Veale

cardiologymedicinepharmacologyfamily medicinechronic obstructive pulmonary diseaserespiratory medicine

1
2
3
4
5
23
10 / page

Mark Brantly

University of Florida

Affiliations

College of Medicine

Pulmonary, Critical Care, and Sleep Medicine

NoneMark Brantly is currently serving as a College Of Medicine faculty at University of Florida.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Mark Brantly

University of Florida

You can click a keyword to filter the displayed items

Video Presentations

Notable Scholarly Works

Notable Federal Grants

Collaborators

Berberine Potentiates Liver Inflammation and Fibrosis in the Pi*Z Haat Transgenic Murine Model. PLoS ONE (2024)

Yuanqing LuNaweed S MohammadJungnam LeeAlek M AranyosKarina A SerbanMark L Brantly

pharmacologyhepatologyliver inflammation

Extracellular Vesicle-Associated Neutrophil Elastase Activates Hepatic Stellate Cells and Promotes Liver Fibrogenesis via Erk1/2 Pathway. bioRxiv (Cold Spring Harbor Laboratory) (2024)

Regina OshinsZachary GreenbergYun-Ling TaiDerrick ZhaoXuan WangBorna MehradMei HeIshan PatelLaith KhartabilHuiping ZhouMark BrantlyNazli Khodayari

enzymesmolecular biologyhepatic stellate cellsbiochemistrycell biology

Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (Sequoia). Gastroenterology (2024)

digestive diseasesmedicineclinical gastroenterologypharmacologyanticoagulantsrandomized controlled trialshematologyliver diseasefamily medicineclinical trialsgastroenterologyhepatology

Mark BrantlyJames StocksJorge LascanoTammy FlaggAnn M. JeffersShuzi Z. OwensTorry A. TuckerMegan DevineNoga AlagemNaveh Tov

pharmacologyreduces inflammationrespiratory medicineanti-inflammatoryaat-deficient individualsinflammation

Liver Characterization of a Cohort of Alpha-1 Antitrypsin Deficiency Patients With and Without Lung Disease. Journal of Clinical and Translational Hepatology (2024)

Naweed MohammadRegina OshinsTongjun GuVirginia ClarkJorge LascanoNaziheh AssarzadeganGeorge MarekMark BrantlyNazli Khodayari

immunologypulmonary diseasespharmacologyclinical immunologyliver characterizationglobal healthhepatologyclinical epidemiologyrespiratory medicinecohort studiestranslational medicinelung disease

Monocyte Nlrp3 Inflammasome and Interleukin-1β Activation Modulated by Alpha-1 Antitrypsin Therapy in Deficient Individuals. Thorax (2024)

Debananda GogoiHoward YuMichelle CaseyRory BairdAzeez YusufLuke FordeMichael E O' BrienJesse R WestTammy FlaggNoel G McElvaneyEdward EdenChristian MuellerMark L BrantlyPatrick GeraghtyEmer P Reeves

immunologymedicinepharmacologyclinical immunologycell signalingcytokinesinnate immune systemimmune responsesdeficient individualsinflammation

Novel Transgenic Humanized Alpha-1 Antitrypsin Deficiency Mouse Model on Murine Serpina1 Null Background. bioRxiv (Cold Spring Harbor Laboratory) (2024)

Regina OshinsAlek M. AranyosSkylar GreyNaweed MohammadYuanqing LuJorge E. LascanoTammy FlaggKarina SerbanMark BrantlyNazli Khodayari

immunologygene therapygeneticsknockout micemolecular biology

Plasma Extracellular Vesicle-Derived Microrna Associated With Human Alpha-1 Antitrypsin Deficiency-Mediated Liver Disease. Journal of Clinical and Translational Hepatology (2024)

Regina OshinsZhiguang HuoZachary GreenbergVirginia ClarkSergio DuarteHuiping ZhouJesse WestMei HeMark BrantlyNazli Khodayari

translational researchliver diseasehepatologyhealth sciencestranslational medicine

Profiling Plasma Extracellular Vesicle-Derived Micrornas for Noninvasive Diagnosis of Liver Disease Associated With Alpha-1 Antitrypsin Deficiency. (2024)

Regina OshinsZhiguang HuoBrittney PooleVirginia ClarkHuiping ZhouJesse WestMark BrantlyZachary GreenbergMei HeNazli Khodayari

immunologydigestive diseasesdermatologypharmacologyhematologyclinical microbiologyliver diseasenoninvasive diagnosismolecular diagnosticsoncologyhepatologyinnovative diagnostics

cardiologymedicinepharmacologyfamily medicinechronic obstructive pulmonary diseaserespiratory medicine

1
2
3
4
5
23
10 / page

Similar Faculty Members

Timothy Scott Blackwell, M.D.

Institution

Vanderbilt University

respiratory medicine

immunology

Samuel French

Institution

University of California, Los Angeles

hepatology

pharmacology

Mary Kay Washington, Ph.D., M.D

Institution

Vanderbilt University

immunology

gastrointestinal oncology

Srinivasan Dasarathy

Institution

Case Western Reserve University

metabolic disorder

hepatotoxicity

Oliver Eickelberg

Institution

University of Pittsburgh

clinical proteomics

diagnosis

Richard Boucher

Institution

University of North Carolina at Chapel Hill

airway mucus

respiratory medicine

Francis X. McCormack

Institution

University of Cincinnati

immune response

pulmonary diseases

Craig McClain

Institution

University of Louisville

hepatology

health science

Camillo Ricordi, M.D.

Institution

University of Miami

stem cell research

immunology

David Geller

Institution

University of Pittsburgh

oncology

surgery

Similar Faculty Members

Timothy Scott Blackwell, M.D.

Institution

Vanderbilt University

respiratory medicine

immunology

Samuel French

Institution

University of California, Los Angeles

hepatology

pharmacology

Mary Kay Washington, Ph.D., M.D

Institution

Vanderbilt University

immunology

gastrointestinal oncology

Srinivasan Dasarathy

Institution

Case Western Reserve University

metabolic disorder

hepatotoxicity

Oliver Eickelberg

Institution

University of Pittsburgh

clinical proteomics

diagnosis

Richard Boucher

Institution

University of North Carolina at Chapel Hill

airway mucus

respiratory medicine

Francis X. McCormack

Institution

University of Cincinnati

immune response

pulmonary diseases

Craig McClain

Institution

University of Louisville

hepatology

health science

Camillo Ricordi, M.D.

Institution

University of Miami

stem cell research

immunology

David Geller

Institution

University of Pittsburgh

oncology

surgery